AVITA Medical, Inc. (RCEL)
Oxford Ledge is still expanding full research coverage of RCEL. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
AVITA Medical develops autologous cell harvesting technology and complementary wound care products for acute wound management across burns, trauma, and surgical applications.
SEC filings
- 8-K Entry into material agreement; Financial statements and exhibits 2026-06-08
- 8-K Departure/election of directors or officers; Shareholder vote results 2026-06-04
- 10-Q Quarterly financial report (unaudited) 2026-05-14
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-14
- 8-K Departure/election of directors or officers; Regulation FD disclosure; Financial statements and exhibits 2026-05-01
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for RCEL. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open RCEL in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.